Literature DB >> 33555615

Consensus statements on the clinical understanding and use of bupropion in Hong Kong.

Wing-King Lee1, Kwok-Leung Au Yeung2, Ho-Bun Lam3, Chi-Keung Wong4, Ting-Chi Wong2, Chi-Kin Fu5, Shiu-Kow Sham2, Ming-Kai Au2, Tat-Chung Lam6, Daniel Ki-Yan Mak7.   

Abstract

OBJECTIVES: To develop a local consensus to guide medical practitioners and psychiatrists on the use of bupropion in different psychiatric conditions in Hong Kong.
METHODS: By utilizing the modified Delphi technique, a group of 10 local physicians with extensive experience in the management of major depressive disorder (MDD) developed and voted (using an anonymous, electronic voting system) on the practicality of recommendation of a set of consensus statements on the clinical use and understanding of bupropion in Hong Kong.
RESULTS: There was a very high degree of agreement among the panelists on the 11 finalized consensus statements.
CONCLUSIONS: The present consensus statements are developed as general recommendations for medical practitioners and psychiatrists to be practically referred to in clinical settings.
© 2021 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Delphi technique; Hong Kong; bupropion; consensus; major depressive disorder

Mesh:

Substances:

Year:  2021        PMID: 33555615      PMCID: PMC7869927          DOI: 10.1111/cns.13376

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  31 in total

Review 1.  Major depressive disorder.

Authors:  M Fava; K S Kendler
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

2.  Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.

Authors:  Georgios Paslakis; Maria Gilles; Michael Deuschle
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

Review 3.  Bupropion: a review of its use in the management of smoking cessation.

Authors:  K J Holm; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 4.  Depression in Parkinson's disease: diagnosis and treatment.

Authors:  Flavio Henrique de Rezende Costa; Ana Lucia Zuma Rosso; Henryk Maultasch; Denise Hack Nicaretta; Maurice Borges Vincent
Journal:  Arq Neuropsiquiatr       Date:  2012-08       Impact factor: 1.420

5.  Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.

Authors:  James W Jefferson; A John Rush; J Craig Nelson; Susan A VanMeter; Alok Krishen; Kenneth D Hampton; Donna S Wightman; Jack G Modell
Journal:  J Clin Psychiatry       Date:  2006-06       Impact factor: 4.384

6.  Alcohol and bupropion pharmacokinetics in healthy male volunteers.

Authors:  J Posner; A Bye; S Jeal; A W Peck; P Whiteman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Medication augmentation after the failure of SSRIs for depression.

Authors:  Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederick Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie M Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

8.  A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.

Authors:  Stephen M. Stahl; James F. Pradko; Barbara R. Haight; Jack G. Modell; Carol B. Rockett; Susan Learned-Coughlin
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

9.  Bupropion poisoning: a case series.

Authors:  Corrine R Balit; Christa N Lynch; Geoffrey K Isbister
Journal:  Med J Aust       Date:  2003-01-20       Impact factor: 7.738

10.  A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients.

Authors:  F W Reimherr; L A Cunningham; S R Batey; J A Johnston; J A Ascher
Journal:  Clin Ther       Date:  1998 May-Jun       Impact factor: 3.393

View more
  1 in total

Review 1.  Application of the Delphi Method in the Study of Depressive Disorder.

Authors:  Hengjin Wu; Linjie Xu; Yu Zheng; Lei Shi; Liangfan Zhai; FengQuan Xu
Journal:  Front Psychiatry       Date:  2022-07-07       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.